Holen Sie sich die Stockscreener-App
13.63
0.04%
0.010
Schlusskurs vom Vortag:
$13.64
Offen:
$13.75
24-Stunden-Volumen:
38,293
Relative Volume:
0.45
Marktkapitalisierung:
$176.35M
Einnahmen:
$14.48M
Nettoeinkommen (Verlust:
$-26.11M
KGV:
-6.0334
EPS:
-2.2591
Netto-Cashflow:
$-23.86M
1W Leistung:
-1.91%
1M Leistung:
-6.61%
6M Leistung:
-20.99%
1J Leistung:
-21.35%
1-Tages-Spanne:
$13.53
$13.78
1-Wochen-Bereich:
$13.29
$14.41
52-Wochen-Spanne:
$13.29
$20.30
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
13.66 | 176.10M | 14.48M | -26.11M | -23.86M | -2.2591 |
VRTX
Vertex Pharmaceuticals Inc
|
548.43 | 133.88B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
843.23 | 83.42B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,025.91 | 62.12B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
154.87 | 25.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
213.90 | 46.30B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-02 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayProfit Growth Outlook - Vinanet
What is HC Wainwright's Forecast for MediWound Q3 Earnings? - MarketBeat
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
Mediwound Ltd (MDWD) Stock News Today - tradingkey.com
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - moomoo.com
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Wall Street Zen Downgrades MediWound (NASDAQ:MDWD) to Strong Sell - MarketBeat
MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips - simplywall.st
MediWound Q2 2026 Earnings Call: Complete Transcript - Sahm
A Quick Look at Today's Ratings for MediWound(MDWD.US), With a Forecast Between $22 to $36 - moomoo.com
MDWD Maintains by Oppenheimer -- Price Target Lowered to $30.00 - GuruFocus
T. Rowe Price Associates (MDWD) discloses 5.0% ownership in Mediwound common stock - Stock Titan
MediWound Ltd. Q2 2026 Earnings Call Summary - finance.yahoo.com
MediWound (MDWD) Earnings Call zu Q2 2026: VALU auf Kurs, Prognose bekräftigt - tradingkey.com
Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target - TradingView
Q2 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus
Mediwound earnings missed by $0.03, revenue topped estimates - Investing.com Canada
MediWound (NASDAQ:MDWD) Issues Earnings Results - MarketBeat
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record - GuruFocus
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ... - ca.finance.yahoo.com
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $22 - moomoo.com
MediWound Q2 2026 Earnings Call Transcript - MarketBeat
MediWound Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: MediWound tops Q2 2026 revenue forecast as shares rise - Investing.com
Mediwound Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Mediwound Ltd. Reaffirms Revenue Guidance for the Full-Year 2026 - marketscreener.com
MediWound Q2 sales beat estimates; EPS miss widens as R&D rises - scanx.trade
MediWound Ltd. (MDWD) Q2 FY2026 earnings call transcript - Yahoo Finance
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates - finance.yahoo.com
MediWound Q2 2026 Results Highlight EscharEx Trial Progress and New NexoBrid BARDA Agreement - TipRanks
MEDIWOUND ($MDWD) Releases Q2 2026 Earnings - Quiver Quantitative
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
MediWound: Q2 Earnings Snapshot - AOL.com
MDWD: Validated enzymatic therapies drive strong growth, targeting $1B+ peak sales in chronic wounds - TradingView
MediWound (NASDAQ: MDWD) revenue drops in H1 2026 but guidance held - Stock Titan
MediWound's Phase III Wound Trial Targets 216 Patients at About 40 Sites - Stock Titan
Technical Reactions to MDWD Trends in Macro Strategies - Stock Traders Daily
Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MediWound (NASDAQ:MDWD) Stock Price Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat
MediWound (MDWD) Expected to Release Earnings on Thursday - MarketBeat
MediWound Ltd. Revenue Breakdown – FWB:M8W - TradingView
Trading the Move, Not the Narrative: (MDWD) Edition - Stock Traders Daily
MediWound to Report Second Quarter 2026 Financial Results - GlobeNewswire
MDWD|Mediwound Ltd|Price:14.500|Chg%:+0.270 - TradingKey
MediWound Ltd. Revenue Breakdown – BOATS:MDWD - TradingView
Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDWD Q1 2026 Earnings: Significant Earnings Beat Despite Revenue AbsenceSpecial Dividend Alert - dars.gov.et
Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.10%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):